{"id":86565,"date":"2016-11-03T17:28:32","date_gmt":"2016-11-03T17:28:32","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=86565"},"modified":"2016-11-03T17:28:32","modified_gmt":"2016-11-03T17:28:32","slug":"global-antisera-and-other-blood-fractions-market-analysis-and-forecast-to-2020","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-antisera-and-other-blood-fractions-market-analysis-and-forecast-to-2020_86565.html","title":{"rendered":"Global Antisera And Other Blood Fractions Market – Analysis and Forecast to 2020"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“IndexBox Marketing”<\/div>\n<\/div>\n<\/div>\n
This report has been designed to provide a detailed analysis of the global antisera and other blood fractions market. It covers the most recent data sets of quantitative medium-term projections, as well as developments in production, trade, consumption and prices.<\/div>\n

From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to 93,254 million USD in 2015. There was an annual increase of +12.8% throughout the analyzed period.<\/em><\/p>\n

According to IndexBox estimates, Switzerland continued to lead the way in global supplies of antisera and other blood fractions. In 2015, Switzerland’s exports of antisera and other blood fractions totaled 24,799 million USD, which accounted for a 27% share of global exports. Germany, USA, Belgium, and the Netherlands were the other key global suppliers of antisera and other blood fractions in 2015, with a 49% combined share of global exports. <\/p>\n

Belgium (+14.3% per year) and Germany (+13.1% per year) were the fastest growing exporters from 2007 to 2015. However, the shares of all major exporters remained within 3 percentage points from their size in 2007 as a result of pronounced export growth in every country.<\/p>\n

On the other hand, Germany (18%, based on value terms), USA (10%), Switzerland (8%), the UK (7%), and Belgium (6%) were the leading destinations of imports of antisera and other blood fractions in 2015. Imports to every leading destination grew at a quick pace over the period under review, with the UK leading the way at a rate of +19.4% per year from 2007 to 2015. Germany’s share in terms of global imports decreased by -5 percentage points, while the balance of the countries maintained their share size within 3 percentage points of its value in 2007.<\/p>\n

Table of Contents<\/strong><\/p>\n

1. INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY<\/p>\n

2. EXECUTIVE SUMMARY
2.1 KEY FINDINGS
2.2 MARKET TRENDS<\/p>\n

3. MARKET OVERVIEW
3.1 MARKET VOLUME AND VALUE
3.2 CONSUMPTION BY COUNTRY
3.3 MARKET OPPORTUNITIES BY COUNTRY
3.4 MARKET FORECAST TO 2020<\/p>\n

4. PRODUCTION
4.1 PRODUCTION IN 2007-2015
4.2 PRODUCTION BY COUNTRY<\/p>\n

5. IMPORTS
5.1 IMPORTS IN 2007-2015
5.2 IMPORTS BY COUNTRY
5.3 IMPORT PRICES BY COUNTRY<\/p>\n

6. EXPORTS
6.1 EXPORTS IN 2007-2015
6.2 EXPORTS BY COUNTRY
6.3 EXPORT PRICES BY COUNTRY<\/p>\n

7. PROFILES OF MAJOR PRODUCERS<\/p>\n

3 easy ways to order<\/p>\n